KRS Capital Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $638K | Sell |
13,781
-880
| -6% | -$40.7K | 0.43% | 54 |
|
|
2025
Q1 | $894K | Buy |
14,661
+2,697
| +23% | +$164K | 0.71% | 29 |
|
|
2024
Q4 | $677K | Sell |
11,964
-77
| -0.6% | -$4.36K | 0.48% | 48 |
|
|
2024
Q3 | $623K | Buy |
12,041
+1,127
| +10% | +$58.3K | 0.45% | 49 |
|
|
2024
Q2 | $453K | Sell |
10,914
-3,346
| -23% | -$139K | 0.34% | 65 |
|
|
2024
Q1 | $773K | Sell |
14,260
-209
| -1% | -$11.3K | 0.62% | 34 |
|
|
2023
Q4 | $742K | Sell |
14,469
-1,106
| -7% | -$56.7K | 0.69% | 37 |
|
|
2023
Q3 | $904K | Sell |
15,575
-855
| -5% | -$49.6K | 0.96% | 24 |
|
|
2023
Q2 | $1.05M | Buy |
16,430
+122
| +0.7% | +$7.8K | 1.05% | 20 |
|
|
2023
Q1 | $1.13M | Buy |
16,308
+219
| +1% | +$15.2K | 1.27% | 17 |
|
|
2022
Q4 | $1.16M | Buy |
16,089
+753
| +5% | +$54.2K | 1.58% | 12 |
|
|
2022
Q3 | $1.09M | Buy |
15,336
+80
| +0.5% | +$5.69K | 1.5% | 13 |
|
|
2022
Q2 | $1.17M | Buy |
15,256
+89
| +0.6% | +$6.85K | 1.67% | 12 |
|
|
2022
Q1 | $1.11M | Sell |
15,167
-67
| -0.4% | -$4.89K | 1.2% | 17 |
|
|
2021
Q4 | $949K | Buy |
+15,234
| New | +$949K | 0.81% | 24 |
|